Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis

References

• Bakland G , Gran JT , Nossent JC . Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis . 2011;70(11):1921–1925. doi:10.1136/ard.2011.151191 21784726
   PubMed Web of Science ®Google Scholar
• Szabo SM , Levy AR , Rao SR , et al. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum . 2011;63(11):3294–3304. doi:10.1002/art.30581 21834064
   PubMed Web of Science ®Google Scholar
• Heslinga SC , Van Dongen CJ , Konings TC , et al. Diastolic left ventricular dysfunction in ankylosing spondylitis–a systematic review and meta-analysis. Semin Arthritis Rheum . 2014;44(1):14–19. doi:10.1016/j.semarthrit.2014.02.004 24655534
   PubMed Web of Science ®Google Scholar
• Mathieu S , Pereira B , Soubrier M . Cardiovascular events in ankylosing spondylitis: an updated meta-analysis. Semin Arthritis Rheum . 2015;44(5):551–555. doi:10.1016/j.semarthrit.2014.10.007 25455683
   PubMed Web of Science ®Google Scholar
• Midtbo H , Gerdts E , Berg IJ , Rollefstad S , Jonsson R , Semb AG . Ankylosing Spondylitis Is Associated with Increased Prevalence of Left Ventricular Hypertrophy. J Rheumatol . 2018;45(9):1249–1255. doi:10.3899/jrheum.171124 29858235
   PubMed Web of Science ®Google Scholar
• Piepoli MF , Hoes AW , Agewall S , et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J . 2016;37(29):2315–2381. doi:10.1093/eurheartj/ehw106 27222591
   PubMed Web of Science ®Google Scholar
• Semb AG , Ikdahl E , Hisdal J , Olsen IC , Rollefstad S . Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases. Int J Cardiol . 2016;223:331–336. doi:10.1016/j.ijcard.2016.08.129 27543704
   PubMed Web of Science ®Google Scholar
• Agca R , Heslinga SC , Rollefstad S , et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis . 2017;76(1):17–28. doi:10.1136/annrheumdis-2016-209775 27697765
   PubMed Web of Science ®Google Scholar
• Hess PL , Al-Khalidi HR , Friedman DJ , et al. The metabolic syndrome and risk of sudden cardiac death: the atherosclerosis risk in communities study. J Am Heart Assoc . 2017;6(8). doi:10.1161/JAHA.117.006103
   Web of Science ®Google Scholar
• Malesci D , Niglio A , Mennillo GA , Buono R , Valentini G , La Montagna G . High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol . 2007;26(5):710–714. doi:10.1007/s10067-006-0380-5 16933103
   PubMed Web of Science ®Google Scholar
• Papadakis JA , Sidiropoulos PI , Karvounaris SA , et al. High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNF-alpha treatment: correlation with disease activity. Clin Exp Rheumatol . 2009;27(2):292–298.19473571
   PubMed Web of Science ®Google Scholar
• Mok CC , Ko GT , Ho LY , Yu KL , Chan PT , To CH . Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken) . 2011;63(2):195–202. doi:10.1002/acr.20363 20890981
   PubMed Web of Science ®Google Scholar
• Maia DG , Augusto KL , Bezerra MC , Rodrigues CEM . Metabolic syndrome in patients with ankylosing spondylitis receiving anti-TNF-alpha therapy: association with predictors of cardiovascular risk. Clin Rheumatol . 2017;36(10):2371–2376. doi:10.1007/s10067-017-3623-8 28391592
   PubMed Web of Science ®Google Scholar
• van der Linden S , Valkenburg HA , Cats A . Evaluation of diagnostic criteria for ankylosing spondylitis. a proposal for modification of the New York criteria. Arthritis Rheum . 1984;27(4):361–368.6231933
   PubMed Web of Science ®Google Scholar
• Chinese Diabetes Society. China Guideline for Type 2 Diabetes: 2013 update. Chin J Diabetes Mellitus . 2014;7(6):447–498.
   Google Scholar
• Chinese overweight/obesity expert consensus committee on medical nutrition therapy. China overweight/obesity medical nutrition treatment expert consensus (2016 edition). Chin J Diabetes Mellitus . 2016;8(9):525–540.
   Google Scholar
• Mancia G , Fagard R , Narkiewicz K , et al. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press . 2014;23(1):3–16. doi:10.3109/08037051.2014.868629 24359485
   PubMed Web of Science ®Google Scholar
• Garrett S , Jenkinson T , Kennedy LG , Whitelock H , Gaisford P , Calin A . A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol . 1994;21(12):2286–2291.7699630
   PubMed Web of Science ®Google Scholar
• Calin A , Garrett S , Whitelock H , et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol . 1994;21(12):2281–2285.7699629
   PubMed Web of Science ®Google Scholar
• Davidson MH , Toth PP . High-density lipoprotein metabolism: potential therapeutic targets. Am J Cardiol . 2007;100(11A):n32–40. doi:10.1016/j.amjcard.2007.08.011 18047851
   PubMed Web of Science ®Google Scholar
• Mathieu S , Gossec L , Dougados M , Soubrier M . Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) . 2011;63(4):557–563. doi:10.1002/acr.20364 20890982
   PubMed Web of Science ®Google Scholar
• Toms TE , Panoulas VF , Douglas KM , et al. Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? Angiology . 2011;62(2):167–175. doi:10.1177/0003319710373749 20682616
   PubMed Web of Science ®Google Scholar
• Lin WY , Liu CS , Li TC , et al. In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study). Ann Rheum Dis . 2008;67(3):432–433. doi:10.1136/ard.2007.073601 18292110
   PubMed Web of Science ®Google Scholar
• Madsen TE , Muhlestein JB , Carlquist JF , et al. Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary disease. Am J Nephrol . 2005;25(1):45–49. doi:10.1159/000084085 15724082
   PubMedGoogle Scholar
• Zhu J , Li A , Jia E , et al. Monosodium urate crystal deposition associated with the progress of radiographic grade at the sacroiliac joint in axial SpA: a dual-energy CT study. Arthritis Res Ther . 2017;19(1):83. doi:10.1186/s13075-017-1286-0 28464949
   PubMed Web of Science ®Google Scholar
• Tantayakom P , Koolvisoot A , Arromdee E , Chiowchanwisawakit P , Muangchan C , Katchamart W . Metabolic syndrome is associated with disease activity in patients with rheumatoid arthritis. Joint Bone Spine . 2016;83(5):563–567. doi:10.1016/j.jbspin.2015.10.016 27238198
   PubMed Web of Science ®Google Scholar
• Fatemi A , Ghanbarian A , Sayedbonakdar Z , Kazemi M , Smiley A . Metabolic syndrome in Iranian patients with systemic lupus erythematosus and its determinants. Clin Rheumatol . 2018;37(6):1521–1528. doi:10.1007/s10067-017-3970-5 29305669
   PubMed Web of Science ®Google Scholar
• Caso F , Del Puente A , Oliviero F , et al. Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study. Clin Rheumatol . 2018;37(3):579–586. doi:10.1007/s10067-017-3975-0 29313273
   PubMed Web of Science ®Google Scholar
• Medina G , Vera-Lastra O , Peralta-Amaro AL , et al. Metabolic syndrome, autoimmunity and rheumatic diseases. Pharmacol Res . 2018;133:277–288. doi:10.1016/j.phrs.2018.01.009 29382608
   PubMed Web of Science ®Google Scholar